About
Molecular Diagnostics
Areas of Focus
Categories
DiagnosticsMountain West
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
4
As Collaborator
5
Total Enrollment
11,997
By Phase
PHASE2: 2PHASE3: 1
By Status
ACTIVE_NOT_RECRUITING: 3TERMINATED: 3COMPLETED: 2WITHDRAWN: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06728319Lead Sponsor
A Multicenter, Retrospective, Chart Review Study Evaluating the Impact and Utility of the Blood-Based Proteomic Integrated Classifier and Auto-Antibody Tests in the Real-World
N/AActive, not recruiting
4,000 participants
Started: Sep 19, 2024 · Completed: Jul 31, 2027
NCT04676386Collaborator
Biomarker Analysis in High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1 Based Therapy With or Without the Addition of Platinum Based Chemotherapy
N/ATerminated
29 participants
Started: Feb 1, 2021 · Completed: Dec 30, 2023
NCT04171492Lead Sponsor
Nodify XL2 Classifier Clinical Utility Study in Low to Moderate Risk Lung Nodules
N/AActive, not recruiting
2,000 participants
Started: Dec 18, 2020 · Completed: Dec 31, 2026
NCT04100330Collaborator
A Study of Ficlatuzumab With HiDAC and HiDAC Alone in Adults With Relapsed or Refractory Acute Myeloid Leukemia
PHASE2Withdrawn
Started: Jan 31, 2020 · Completed: Mar 27, 2020
NCT03951012Collaborator
Use Peripheral Blood Proteomics to Predict the Treatment Response and Toxicities in NSCLC Immunotherapy
N/ATerminated
29 participants
Started: Apr 15, 2019 · Completed: Sep 8, 2023
Locations (1)
Headquarters
Louisville, CO, United States
Map
Loading map...